chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 days after mist given upper respiratory conditions started. Fever, congested, feeling bad.
Patient presented to ED with cramping in the hands as well as feet along with numbness and tingling sensation for 3 days prior.   Patient was diagnosed with hypokalemia, hypocalcemia and hypomagnesia. Patient also was jaundice with LFT abnormalities.    Patient also showed prolonged QT interval and U waves and T wave inversion which was consistent with nikelekam T waves.
Pt admitted to Hosp 18nov96 w/ c/o weakness  cephalgia. dx: GBS. D/C from Aehab 18dec96
Post vax, the pt developed URI symptoms, macular rash on trunk, extremities, and face.
Persistent pain in injection site lasted several weeks after injection on Oct. 24, 2017. As of Jan. 16, 2018, continued acute pain in area of rotator cuff, top of shoulder to nape of neck. Saw primary care dr in December who suggested heat and ALEVE; no relief. Massages help temporarily, 3-4 days. Yoga also helps temporarily 1-2 days.
All joints aching, headache, temp escalating to 101.7 by 11 PM, gout like nerve pain in hands, feet, ear, back pain at both kidneys. No treatment-rest and fluids.
received vaccine at 02:30 pm 12/26/20, by 09:30 12/27/20  had chills, muscle aches, headache, sinus pressure, fatigue, and moderate soreness in arm of injection, symptoms resolved as of 12/28/20  09:30
This spontaneous report as received from a physician refers to a 79 year old female patient. The patient had no pertinent medical history and no drug allergy. On approximately 17-APR-2013 the patient was vaccinated with ZOSTAVAX for shingles prevention. Lot # was unspecified. Concomitant therapies included TOPROL XL TABLETS, ADVIL, SYNTHROID, metoprolol, amlodipine, estrogens, PREMARIN and vitamin D. The physician reported that on 01-MAY-2013 the patient experienced a "sudden onset of right-sided pain down her leg and a zoster-like lesion over the area where ZOSTAVAX was administered about two weeks ago". Physician reported that the patient had been diagnosed by her primary physician. He stated that the patient was currently being treated for Herpes Zoster with VALTREX. Outcome of event was reported as not recovered. The patient came to doctor's office to seek medical attention. Additional information has been requested.
Patient became dizzy, passed out and hit head on wall,  Ambulance called, taken to nearest Hospital.
This nurse asked client if she wanted to receive influenza vaccine while laying on the cot since the client has a history of "hyporesponsive collapse" on 10/23/2015, per documentation by the RN at that time on her paper chart. Client stated she thought she would be okay sitting in the chair to receive the vaccine. This nurse administered the vaccine. This nurse asked the client if she was feeling okay. The client verified that she was. This nurse looked at computer to print the client's record, then looked back at the client to see her eyes closed and sliding sideways out of chair. This nurse was unable to catch the client and the client landed on floor. This nurse called for help and rolled client onto her back with knees bent, calling her name. The client's eyes opened. The client became more alert and responded to her name. A cot was brought into the room and the client was helped to a sitting position on it. The client stated she was alright and did not want to lay down. When asked how the client felt she stated, "frustrated." She stated she did not remember what happened and did not feel dizzy or bad before she "blacked out." The client was given juice to drink and a cool compress was placed on her neck. The client's father stated she ate lunch around noon and was surprised because, "This hasn't happened for years." This nurse continued to observed the client. The client was alert and oriented to person, place, and time. She denied any pain. After several minutes, the client stated she was "okay" and able to stand up and walk without assistance or support. This nurse told the client to sit in the waiting room for a few more minutes. The client and father stated understanding. After a few minutes, the client stated she was still feeling okay, denied pain and dizziness, and left with her father.
Employee reported developing a rash on her face and neck about an hour after receiving the vaccine. She stated the rash was red with raised bumps, itchy and warmth. The rash was reported to be from bilateral cheek bones down neck to collar bones. She states she took Benadryl and was not seen by any doctors. She mentioned the rash subsided around two days after receiving the vaccine.
Patient was fine & going home in morning. Was given pneumonia shot & went into total delirium. 12-25-12 to 1-1-13 in hosp. then released to re-hab for 10 days. Doctors never found test results to back up this behavior and expensive stay. Only thing to go on was the shot. Why do they need to push them on you?
injuries resulting from Zostavax use: Herpes Zoster; injuries resulting from Zostavax use: Herpes Zoster; products liability - defective design; manufacturing defect; Information has been received from a lawyer regarding a case in litigation concerning a currently 69 years old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  The patient was prescribed the Zoster Vaccine Live (ZOSTAVAX) vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In April 2017, the patient was administered zoster vaccine live(ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) by a pharmacist. On an unknown date, the patient was treated by a physician for the following injuries resulting from the patient's Zoster Vaccine Live (ZOSTAVAX) use: Herpes Zoster.  The patient claimed damages as a result of: Injury to themselves; Economic losses.  The following claims were asserted: negligence; products liability - defective design; products liability - manufacturing defect; products liability-failure to warn; breach of express warranty; breach of implied warranty; fraudulent misrepresentation; fraudulent concealment; negligent misrepresentation; unjust enrichment; strict liability; consumer fraud; punitive damages.  The outcome of the events was unknown. Causality assessments were related.
Menveo only liquid given; Menveo only liquid given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 19-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA724Z, expiry date 30-SEP-2023) for prophylaxis.   On 22-AUG-2023, the patient received Menveo. On 22-AUG-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Menveo only liquid given) and inappropriate dose of vaccine administered (Verbatim: Menveo only liquid given).The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: Receipt Date: 23-AUG-2023 The reporter called to report that only the liquid portion of Menveo was administered to a patient, which led to inappropriate preparation of medication and Inappropriate dose of vaccine administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up via email.
No further AE; 12 month old patient received both PROQUAD and VARlVAX; 12 month old patient received both PROQUAD and VARlVAX; This spontaneous report as received from a medical assistant refers to a 12-month-old, non-pregnant female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.    On 27-JAN-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) intramuscularly, lot # T010314 has been verified to be a valid lot number, expiration date: 24-MAR-2022 (exact dose, anatomical location were not reported) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) albumin status rHA, intramuscularly, lot # T013540 has been verified to be a valid lot number, expiration date: 17-OCT-2021 (exact dose, anatomical location were not reported); both for prophylaxis. Therefore the patient experienced inappropriate schedule of product administration and overdose. The patient was not exhibiting any adverse symptoms and no treatment was given. The outcome of the events was reported as recovered on 27-JAN-2021.
Pt vaccinated DTP/OPV cried non-stop for 3 hrs, started approx. 8 hrs after vacc. given. Higher pitched cry tahn normal for him. Increased sleep X 24 hrs.
Our family had Covid in December of 2020.  At that time patient tested "inconclusive" for Covid.  However, an antibody test was performed in July which indicated he did have Covid antibodies. Patient received his first Covid vaccine on Friday, August 13th.  By the evening of Saturday, August 14th he was feeling "off", sick, and tired.  From 12:00 a.m. to 4:30/5:00 a.m. on Sunday, August 15th he vomited approximately 4/5 times.  Around 7:00 a.m. he started having body aches, chills, headaches, stomach aches and nausea.  Around 9:00 a.m. he complained of chest pain and difficulty breathing. At this time I took him to the ER. He has heart disease so we have to take any illness seriously.  He also used to get dehydrated when he was sick with cold/strep/virus, etc. or on hot days.  He had an IV of fluid to help with dehydration, Tylenol for the pain, and a nausea medication. He had an EKG, chest xray, blood work, and a urine test.  I believe all results were normal/ok. He was discharged and we were told to keep an eye on his symptoms for the next few days and to follow up with his doctor.
On 11/28/08 pt was in clinic and C/O welts on thigh; Shoulder reaction to flu shot: cough and sore throat. Ongoing since flu shot on 10/14/08; cough and sore throat since 3 days. S/S - Welts to both thighs, left shoulder, and back itching, swollen lips; cough throat. Vital signs noted. Pt presents to clinic with c/o above sx. Pt. states that since receiving his flu shot. he has been experiencing these sx which last approx. 1 1/2 days, disappear, and then reoccur, itching but denies any pain; denies any SOB. chest pain or throat swelling. Pt has not had a reaction to any other flu shot in the past.  Large circular, raised welts noted to bilateral upper thighs/hips left side and shoulders erythema noted to left shoulder. Cough is noted as productive of white mucous. Lung sounds clear bilaterally; respirations regular and non-labored; cars clear and WNL; nasal passages bright red with clear exudate; throat without swelling or erythema; no pain/tenderness noted with palpation to frontal sinuses or submandibular lymph nodes. Pt. reports use of OTC Ibuprofen. Alka-Seltzer Cough and cold with some relief. Pt was given BENADRYL.
This spontaneous report as received from a healthcare worker refers to a one unspecified patient of unknown age and gender. On 14-AUG-2015, the patient was vaccinated with a dose of improperly stored M-M-R II (reported lot number: 1010596, exp.date: 06-APR-2017) (strength, dose and route were not reported) which was exposed to a temperature outside of the recommended range. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Welt on upper arm; Rash on upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Welt on upper arm) and VACCINATION SITE RASH (Rash on upper arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (Welt on upper arm) and VACCINATION SITE RASH (Rash on upper arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE URTICARIA (Welt on upper arm) and VACCINATION SITE RASH (Rash on upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported
my blood pressure a bit high; pressure over my left eye is extremely intense; Nausea after second vaccine/nausea is periodic; Fatigue after second vaccine; Headache (Scale of 1-10 it is a 6) after second vaccine/non-stop headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (my blood pressure a bit high), OCULAR DISCOMFORT (pressure over my left eye is extremely intense), NAUSEA (Nausea after second vaccine/nausea is periodic), FATIGUE (Fatigue after second vaccine) and HEADACHE (Headache (Scale of 1-10 it is a 6) after second vaccine/non-stop headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050021A and 002C26A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy, Allergy (To Cardboard) and Allergy (To Paper). Concomitant products included ESTRADIOL (ESTROGEN), PROGESTERONE, PROBIOTICS NOS, VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced NAUSEA (Nausea after second vaccine/nausea is periodic), FATIGUE (Fatigue after second vaccine), HEADACHE (Headache (Scale of 1-10 it is a 6) after second vaccine/non-stop headache) and MYALGIA (body aches). On an unknown date, the patient experienced HYPERTENSION (my blood pressure a bit high) and OCULAR DISCOMFORT (pressure over my left eye is extremely intense). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. On 08-Jun-2021, FATIGUE (Fatigue after second vaccine) had resolved. At the time of the report, HYPERTENSION (my blood pressure a bit high) and OCULAR DISCOMFORT (pressure over my left eye is extremely intense) outcome was unknown, NAUSEA (Nausea after second vaccine/nausea is periodic) and HEADACHE (Headache (Scale of 1-10 it is a 6) after second vaccine/non-stop headache) had not resolved and MYALGIA (body aches) had resolved.            The patient reported that when she progesterone and estrogen pills were stopped, nausea stopped.   Other concomitant medications included: antihistamines twice daily  It was also reported that treatment medication Tylenol also gave nausea, therefore stopped taking   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received and Updated patient details: Height, Weight, Race; Updated Medical History: Allergies; Updated Events: Body aches, Blood pressure, Intraocular pressure; Updated outcomes: Nausea- From recovered to ongoing;
laryngeal mass; speech disorder; vocal cord neoplasm; Loss of voice; This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (Loss of voice), LARYNGEAL MASS (laryngeal mass), SPEECH DISORDER (speech disorder) and LARYNGEAL NEOPLASM (vocal cord neoplasm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZZMZ0A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included Head injury in December 2020 and Fall on 24-Dec-2020. Concomitant products included PREDNISONE for Rheumatoid arthritis.   In 2001, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg once a week. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced APHONIA (Loss of voice), SPEECH DISORDER (speech disorder) and LARYNGEAL NEOPLASM (vocal cord neoplasm). In April 2021, the patient experienced LARYNGEAL MASS (laryngeal mass). The patient was treated with Surgery (Tumour removal) for Laryngeal mass and Surgery (Tumor removal) for Laryngeal neoplasm. In April 2021, APHONIA (Loss of voice), LARYNGEAL MASS (laryngeal mass), SPEECH DISORDER (speech disorder) and LARYNGEAL NEOPLASM (vocal cord neoplasm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, Computerised tomogram: unknown (Inconclusive) Inconclusive. In March 2021, Endoscopy: abnormal (abnormal) Lump on vocal cord.      Action taken with mRNA-1273 in response to events was not applicable.  Patient had 2 Outpatient surgery and removed everything out. Tumor was non-cancerous.; Sender's Comments: Based on reporter's causality (laryngeal mass was the etiology that must developed all symptoms, resolved after surgical treatment) the event is assessed as unlikely related to mRNA-1273
About 35-45 minutes after receiving my vaccine, I felt almost like I was drunk. I was in a store and become a bit disoriented. It lasted for roughly 1 hour. For the rest of the day I dealt with a massive migraine and nausea and exhaustion. I also kept falling asleep while sitting up the first day. The headache and nausea lasted for 2.5 days but I did take Summatriptan for some relief (as prescribed by my doctor previously on an as need basis)
T105R w/in 12 hrs of immun; no response to Tylenol; PT had T103-104R x 1 wk p/immun; no rx x/Tylenol;
Loss of appetite. Pain on hip/nerve pain. On 1/2/16 went to Hospital. Had stroke, brain bleed, heart attack. Also had reaction to medications while on hospital.
The next morning at 4:00AM, 16 hours after the vaccination I had weakness, headache, and tiredness.
BREATHING GOT WORST; ANKLES SWELLING; HANDS SWELLING; SORE THROAT; TONGUE SORE; FEVER; This spontaneous report received from a patient concerned an elderly female. The patient's height, and weight were not reported. The patient's past medical history included heart attack, and concurrent conditions included copd, bad heart, and pneumonia, and other pre-existing medical conditions included the patient had no history of allergy to vaccine, drug, or food and no past history of similar event.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced ankles swelling. On MAR-2021, the subject experienced hands swelling. On MAR-2021, the subject experienced sore throat. On MAR-2021, the subject experienced tongue sore. On MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F, and Investigation (NR: not provided) UNKNOWN. On 29-MAR-2021, the subject experienced breathing got worst. Laboratory data included: COVID-19 virus test (NR: not provided) Negative. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from breathing got worst, and the outcome of sore throat, ankles swelling, hands swelling, tongue sore and fever was not reported. This report was non-serious.; Sender's Comments: V1: Medical assessment comment not required as per the standard operating procedure as the case is assessed as non-serious.
Initial report received on 20 November 2007 from a health care provider. A 48-year-old female patient had received an injection of Adacel, lot number C2759AA, on 21 August 2007. Per The reporter, the "patient has dystonia" which required hospitalization. The date of onset was not provided. The reporter refused to provide additional information, but provided contact information for the responsible physician. Other medications were unknown, and past medical history and whether there was illness at the time of vaccination were not provided. At the time of this report, the patient had not recovered.
Shot was received a few days after end of menstrual period. Patient experienced significant fatigue, feeling weak and light headed, had very heavy period the following month.
He started experiencing a cough the next day with no other symptoms; This is a spontaneous report from a contactable consumer. This consumer (patient's parent) reported for a 12-year-old male patient (reporter's son). A 12-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Consumer reported, ''my son just turned 12 years old on 28Jul2009. He received his 1st dose of the Pfizer covid-19 vaccine on 03Aug2021. He started experiencing a cough the next day with no other symptoms. His cough still lingers daily. It was just one cough every so often. He had not been sick nor in contact with anyone with the covid virus. He was not sick nor running a fever. You should know this symptom was caused by the vaccine''. The clinical outcome of the event was not recovered at the time of report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Immediate swelling of throat, face, hands. Numbness in arms and legs. Dizziness and fatigue.
This spontaneous report as received from a licensed practical nurse (who was also the patient's mother) via a company representative refers to a male patient of unknown age. No information regarding the patient's medical history or concurrent conditions was provided. On 29-APR-2016, the patient was vaccinated with the first dose of GARDASIL injection (dose, route of administration, lot# and expiry date were not reported). On 16-MAY-2016 (an 18 day interval), the patient was vaccinated with the second dose of GARDASIL injection (dose, route of administration, lot# and expiry date were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
about a month + I got Covid as did my daughter and her kids and it came from my other grandsons daycare  Shortness of breath Extreme tiredness Wheezing Cough
ON WED APRIL  14 2021 , FELT OFF BALANCE AND DIZZY, NAUSEA , BLURRED VISION, HEADACHE / WENT TO URGENT CARE. BP WAS 180/90, I WAS TOLD TO GO TO HOSPITAL TO GET CHECK FOR SIGNS OF STROKE. WENT TO HOSPITAL , THEY RAN ALOT TEST - BLOOD WORK, CT-MRI TEST.  EVERYTHING CAME BACK OK FOR NO SIGN OF STROKE.